Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.

Fabiola Atzeni, Piercarlo Sarzi-Puttini, Donata Dell' Acqua, Simona de Portu, Germana Cecchini, Carola Cruini, Mario Carrabba, Pier Luigi Meroni

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.'. Together they form a unique fingerprint.

Medicine & Life Sciences